NCT06756321 2025-01-03A Study of CAR T-Cells in Relapsed/Refractory Hematologic MalignancyAffiliated Hospital of Nantong UniversityPhase EARLY_PHASE1 Recruiting9 enrolled
NCT06532643 2024-09-19Safety and Efficacy of Anti-CD20/CD30 CAR-T Cells in Subjects with Relapsed/Refractory LymphomaShanghai First Song Biotechnology Co., LTDPhase EARLY_PHASE1 Recruiting9 enrolled